Drug Clinical Trials List

Display 221 - 230 from 730

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
International, randomized, open label study to compare the safety and efficacy of lixisenatide vs sulfonylurea on top of basal insulin treatment in Type 2 Diabetes Mellitus subjects who elect to fast during Ramadan	Sanofi	Terminated	Lixisenatide	3	LPS14410	KKUH
Inflammatory Regulation Effect of NAC on COVID-19 Treatment	KKUH	Ongoing	N-acetylcysteine	3	E-20-4934	King Khalid University Hospital (Riyadh)
Inflammatory Regulation Effect of NAC on COVID-19 Treatment	KKUH	Ongoing	N-acetylcysteine	3	E-20-4934	King Khalid University Hospital (Riyadh)
Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease.	Celgene	Ongoing	Ozanimod HCl	3	RPC01-3201	KAUH-J
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma	SWOG (Southwest Oncology Group)	Ongoing	Ibrutinib	3	A051301	KFSH&RC-R
HELIOS-B: A Phase 3, Randomized, Doubleblind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy)	Alnylam Pharmaceuticals.	Ongoing	ALN-TTRSC02 (Vutrisiran)	3	ALN-TTRSC02-003	King Khalid University Hospital (Riyadh)
Global Study to Assess the Addition of Bevacizumab to Carboplatin and Paclitaxel as Front-line Treatment of Epithelial Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma	Roche	Completed	Bevacizumab	3	MO22923	KFMC
Freeze dried kale to go, new superfood supplement to reduce metabolic risk in Saudi subjects	The National Plan for Science,Technology and Innovation	Ongoing	Freeze dried kale	3	H-01-R-002	King Khalid University Hospital (Riyadh)
Follow-up of Phase I/II study of CaspaCIDe T cells (BPX-501) from an HLA-partially matched family donor after negative selection of TCR αβ+T cells in pediatric patients affected by hematological disorders	Bellicum Pharmaceuticals	Ongoing	Rimiducid	1/2	CT17-008-R	NGHA-R
Fluids in Septic Shock: A Randomized control Trial	McMaster University	Completed	Sodium Chloride	3	20120802	King Fahad University Hospital (Al-Khobar)